论文部分内容阅读
报告手术治疗中、晚期大肝癌54例。其中8例经肝动脉栓塞化疗（HACE）后行肝切除术。25例手术切除瘤体后作HACE以达到消除或控制残店的目的。不能切除的大肝癌转变成为可以切除与手术技术的改进和手术器械的改革有关。手术均采用彭氏多功能手术解剖器（PMOD），实行刮吸法断肝技术，术中出血量少且安全易行。手术切除40例，切除率74％。在常温下阻断入肝血流时间可以超过15～20min。术后合并症24例，血不疑是大肝癌切除后最严重的合并症之一，可能与肝功能损害及大量输入库存血有关。胸腔积液是肝切除后最常见的合并症，右肝切除术后发生率更高。
Report surgery in the middle and late stage 54 cases of liver cancer. Eight of them received hepatectomy after hepatic artery embolization chemotherapy (HACE). Twenty-five patients were treated with HACE after surgical removal of the tumor to achieve the purpose of eliminating or controlling the residual product. The transformation of unresectable large liver cancer into resectable is related to the improvement of surgical techniques and the reform of surgical instruments. All patients were treated with Peng’s multi-function surgical dissector (PMOD). The scraping method was used to cut off the liver. The amount of bleeding was small and safe. Surgical resection in 40 cases, the resection rate was 74%. Blocking the hepatic blood flow at room temperature can exceed 15 to 20 minutes. Postoperative complications occurred in 24 cases. Blood was undoubtedly one of the most serious complications after resection of large hepatocellular carcinoma. It may be related to hepatic impairment and massive blood transfusion. Pleural effusion is the most common complication after hepatectomy, with a higher incidence after right hepatectomy.